159 related articles for article (PubMed ID: 31188999)
1. Botulinum toxin type A in chronic neuropathic pain in refractory leprosy.
Sousa EJS; Sousa GC; Baia VF; Somensi DN; Xavier MB
Arq Neuropsiquiatr; 2019 May; 77(5):346-351. PubMed ID: 31188999
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type A for neuropathic pain in patients with spinal cord injury.
Han ZA; Song DH; Oh HM; Chung ME
Ann Neurol; 2016 Apr; 79(4):569-78. PubMed ID: 26814620
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound-Guided Nerve Block with Botulinum Toxin Type A for Intractable Neuropathic Pain.
Moon YE; Choi JH; Park HJ; Park JH; Kim JH
Toxins (Basel); 2016 Jan; 8(1):. PubMed ID: 26761032
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain.
Ranoux D; Attal N; Morain F; Bouhassira D
Ann Neurol; 2008 Sep; 64(3):274-83. PubMed ID: 18546285
[TBL] [Abstract][Full Text] [Related]
5. Botulinum Toxin-A for Painful Diabetic Neuropathy: A Meta-Analysis.
Lakhan SE; Velasco DN; Tepper D
Pain Med; 2015 Sep; 16(9):1773-80. PubMed ID: 25800040
[TBL] [Abstract][Full Text] [Related]
6. Incobotulinum Toxin-A Improves Post-Surgical and Post-Radiation Pain in Cancer Patients.
Rostami R; Mittal SO; Radmand R; Jabbari B
Toxins (Basel); 2016 Jan; 8(1):. PubMed ID: 26771640
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin type-A (BOTOX) in the treatment of occipital neuralgia: a pilot study.
Taylor M; Silva S; Cottrell C
Headache; 2008; 48(10):1476-81. PubMed ID: 19076646
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial of botulinum toxin A for treating neuropathic pain in patients with spinal cord injury.
Li G; Lv CA; Tian L; Jin LJ; Sun P; Zhao W
Medicine (Baltimore); 2017 May; 96(20):e6919. PubMed ID: 28514309
[TBL] [Abstract][Full Text] [Related]
9. Effect of botulinum toxin on quality of life of patients with chronic myofascial pain.
Miotto E; Salvatore Freitas KM; Mori AA; Valarelli FP; Gobbi de Oliveira RC; Oliveira RC
Pain Manag; 2021 Sep; 11(5):583-593. PubMed ID: 33980033
[No Abstract] [Full Text] [Related]
10. Revealing the Therapeutic Potential of Botulinum Neurotoxin Type A in Counteracting Paralysis and Neuropathic Pain in Spinally Injured Mice.
Vacca V; Madaro L; De Angelis F; Proietti D; Cobianchi S; Orsini T; Puri PL; Luvisetto S; Pavone F; Marinelli S
Toxins (Basel); 2020 Jul; 12(8):. PubMed ID: 32751937
[TBL] [Abstract][Full Text] [Related]
11. [Subcutaneous botulinum toxin in the treatment of peripheral neuropathic pain].
Puentes Gutiérrez AB; García Bascones M; Puentes Gutiérrez R; Díaz Jiménez M
Rehabilitacion (Madr); 2019; 53(2):131-135. PubMed ID: 31186096
[TBL] [Abstract][Full Text] [Related]
12. Botulinum neurotoxin type A for the treatment of pain: not just in migraine and trigeminal neuralgia.
Sandrini G; De Icco R; Tassorelli C; Smania N; Tamburin S
J Headache Pain; 2017 Dec; 18(1):38. PubMed ID: 28324318
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin - neuropathic pain: Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial.
Br Dent J; 2016 Aug; 221(3):126. PubMed ID: 27514345
[TBL] [Abstract][Full Text] [Related]
14. Effect of subcutaneous injection of botulinum toxin A on spinal cord injury-associated neuropathic pain.
Han ZA; Song DH; Chung ME
Spinal Cord; 2014 Jun; 52 Suppl 1():S5-6. PubMed ID: 24902645
[TBL] [Abstract][Full Text] [Related]
15. Use of botulinum toxin A for drug-refractory trigeminal neuralgia: preliminary report.
Bohluli B; Motamedi MH; Bagheri SC; Bayat M; Lassemi E; Navi F; Moharamnejad N
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jan; 111(1):47-50. PubMed ID: 20674409
[TBL] [Abstract][Full Text] [Related]
16. Impact of botulinum toxin injections on quality of life and self-esteem in patients with blepharospasm.
Tang M; Li W; Ji F; Li X; Zhang Y; Liu P
Psychol Health Med; 2019 Jun; 24(5):513-518. PubMed ID: 30463432
[TBL] [Abstract][Full Text] [Related]
17. A preliminary comparison of the efficacy and tolerability of botulinum toxin serotypes A and B in the treatment of myofascial pain syndrome: a retrospective, open-label chart review.
Lang AM
Clin Ther; 2003 Aug; 25(8):2268-78. PubMed ID: 14512133
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of botulinum toxin type A in trigeminal neuralgia.
Zúñiga C; Díaz S; Piedimonte F; Micheli F
Arq Neuropsiquiatr; 2008 Sep; 66(3A):500-3. PubMed ID: 18813708
[TBL] [Abstract][Full Text] [Related]
19. Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation.
Intiso D; Basciani M; Santamato A; Intiso M; Di Rienzo F
Toxins (Basel); 2015 Jun; 7(7):2454-80. PubMed ID: 26134256
[TBL] [Abstract][Full Text] [Related]
20. Botulinum Toxin Type-A (Botulax
Kim H; Jang B; Kim ST
Toxins (Basel); 2021 May; 13(5):. PubMed ID: 34064451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
